CLGN - CIK 0001631487
The table below shows CollPlant Biotechnologies Ltd's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $18.92M | $22.28M | $36.29M | $17.48M | $3.67M | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $250.00K | - | $9.00K | $277.00K | - | - |
| Inventory | $439.00K | $1.55M | $1.36M | $940.00K | $730.00K | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $20.34M |
| $34.86M |
| $38.27M |
| $49.77M |
| $5.49M |
| - |
| Property, plant & equipment | $2.56M | $2.93M | $2.92M | $2.12M | $2.25M | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $26.57M | $41.57M | $44.41M | $55.02M | $10.95M | $9.55M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $3.24M | $2.78M | $2.36M | $2.93M | $2.18M | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $5.84M | $5.53M | $4.91M | $5.58M | $5.17M | $7.72M |
| Retained earnings | -$105.15M | -$87.67M | -$80.94M | -$65.95M | -$70.83M | - |
| Total equity | $20.73M | $36.04M | $39.51M | $49.44M | $5.78M | - |